+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Immunochemistry Market to 2027 - Regional Analysis and Forecasts by Application; Product; End User, and Country

  • ID: 4987822
  • Report
  • January 2020
  • Region: Europe
  • 180 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE
The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.

The growth of the immunochemistry market is primarily attributed to the significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes in the region. However, shortage of skilled professionals is likely to have a negative impact on market growth. On the other hand, rising healthcare expenditure in Europe is likely to have a positive impact on the growth of the Europe immunochemistry market in the coming years.

The growth of the immunochemistry market is primarily attributed to the significantly increased prevalence of cardiovascular diseases and the rising incidence of diabetes in the region. However, a shortage of skilled professionals is likely to have a negative impact on market growth. On the other hand, rising healthcare expenditure in Europe is expected to have a positive impact on the growth of the European immunochemistry market in the coming years.

Cardiovascular diseases (CVDs) are likely to endure the most significant cause of mortality and morbidity worldwide. The CVDs include the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Some of the significant lifestyle factors which lead to cardiovascular disease and difficulties are the use of tobacco, unhealthy diet, and physical inactivity increases the risk of heart attacks and strokes. Whereas the other risk factors for cardiovascular diseases are diabetes, high blood pressure, increased level of cholesterol levels. CVDs are one of the major leading causes of death that affect more people as compared to any other disease across the globe. According to the World Health Organization, cardiovascular diseases are the number one cause of death across the world. According to the WHO data published in 2017, states that, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Among these, about 85% death estimated due to stroke and heart attack that are mainly caused due to fatty deposits that block the blood vessels that prevent blood from flowing to the brain or heart. Also, strokes are caused due to bleeding from a blood vessel in the brain or from blood clots. Heart attacks and strokes are caused due to increased consumption of tobacco use, unhealthy diet and obesity, physical inactivity and rising alcohol consumption, hypertension, and diabetes.

As per the data estimated by the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in Europe every year. The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the primary reason for the death of men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which are around half of the US adult population, suffer from cardiovascular disease.

In 2018, the diagnostics segment accounted for the largest market share in the Europe immunohistochemistry market by the application. The advancements in immunohistochemistry have extended the use of technology to diagnose various type of chronic diseases. The molecular diagnostics appplications have enabled to the treated patient as per their genetic make-up also the diagnosis through immunohistochemistry has increased the use in the precision medicine. Also, the cost-effective nature of the immunochemistry is driving significant growth across the region.

In 2018, the antibodies held the largest market share of the immunochemistry market, by product. This segment is also expected to dominate the market in 2027. Moreover, the reagent segment is anticipated to register the highest CAGR in the market during the forecast period, since they form an essential component of any reaction and can be chosen as per the result to be obtained.

In 2018, the hospital & diagnostic laboratories segment held the most significant market share of the immunochemistry market, by the end-user. This segment is also expected to dominate the market in 2027. Also, the segment is expected to grow at the fastest rate during the coming years owing to the rise in the prevalence of infectious diseases, cancer, and autoimmune disorders.

Some of the major primary and secondary sources for immunochemistry included in the report are, Federation of AIDS Organisations (AFAO), Agência Nacional de Vigilância Sanitária (ANVISA), HIV and AIDS organization (AVERT), Centers for Disease Control and Prevention (CDC), Centers for Diabetes and Endocrinology (CDE), Council of Scientific and Industrial Research (CSIR) and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe immunochemistry market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance

2. Europe Immunochemistry Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Immunochemistry Market - Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 Europe Immunochemistry Market - By Product
4.2.2 Europe Immunochemistry Market - By Application
4.2.3 Europe Immunochemistry Market - By End User
4.2.4 Europe Immunochemistry Market - By Country
4.3 PEST Analysis

5. Europe Immunochemistry Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Significantly Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rising Incidence of Diabetes
5.2 Key Market Restraints
5.2.1 Shortage of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trends
5.4.1 Rising Future Conferences and Workshops
5.5 Impact Analysis

6. Immunochemistry Market - Europe Analysis
6.1 Europe Immunochemistry Market Revenue Forecasts And Analysis
6.2 Performance of Key Players

7. Europe Immunochemistry Market Analysis - By Application
7.1 Overview
7.2 Europe Immunochemistry Market, By Application, 2018 & 2027 (%)
7.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.3.1.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.4 Diagnostics
7.4.1 Overview
7.4.2 Europe Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Cancer
7.4.3.1 Overview
7.4.3.2 Europe Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Infectious Diseases
7.4.4.1 Overview
7.4.4.2 Europe Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Autoimmune Diseases
7.4.5.1 Overview
7.4.5.2 Europe Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Nephrological Diseases
7.4.6.1 Overview
7.4.6.2 Europe Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Drug Testing
7.5.1 Overview
7.5.2 Europe Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Immunochemistry Market Analysis - By Product
8.1 Overview
8.2 Europe Immunochemistry Market, By Product, 2018 & 2027 (%)
8.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Antibodies Market
8.4.1 Overview
8.4.2 Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.3 Primary Antibodies
8.4.3.1 Overview
8.4.3.2 Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4 Secondary Antibodies
8.4.4.1 Overview
8.4.4.2 Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Equipment
8.5.1 Overview
8.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.3 Slide Staining Systems
8.5.3.1 Overview
8.5.3.2 Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4 Tissue Microarrays
8.5.4.1 Overview
8.5.4.2 Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5 Slide Scanners
8.5.5.1 Overview
8.5.5.2 Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6 Other Equipment
8.5.6.1 Overview
8.5.6.2 Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Reagents
8.6.1 Overview
8.6.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.3 Histological Stains
8.6.3.1 Overview
8.6.3.2 Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.4 Blocking & Fixation Reagents
8.6.4.1 Overview
8.6.4.2 Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.5 Chromogenic Substrates
8.6.5.1 Overview
8.6.5.2 Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.6 Stabilizers
8.6.6.1 Overview
8.6.6.2 Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.7 Proteolytic Enzymes
8.6.7.1 Overview
8.6.7.2 Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.8 Solvents
8.6.8.1 Overview
8.6.8.2 Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Kits
8.7.1 Overview
8.7.2 Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Immunochemistry Market Analysis - By End User
9.1 Overview
9.2 Europe Immunochemistry Market, By End User, 2018 & 2027 (%)
9.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital & Diagnostic Laboratories
9.4.1 Overview
9.4.2 Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Institutes
9.5.1 Overview
9.5.2 Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others End Users
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Europe Immunochemistry Market Revenue and Forecasts To 2027
10.1 Overview
10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.2.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
10.1.6 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.6.2.1 UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.6.3.1 UK Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.2 UK Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.3 UK Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.4 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.7 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.7.2.1 Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.7.3.1 Germany Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.2 Germany Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.3 Germany Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.4 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.8.2.1 France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3.1 France Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.2 France Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.3 France Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.4 France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.9.2.1 Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.9.3.1 Italy Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.2 Italy Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.3 Italy Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.4 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.10 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.2 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.10.2.1 Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3.1 Spain Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.2 Spain Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.3 Spain Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.4 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Immunochemistry Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview

12. Immunohistochemistry Market-Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT ANALYSIS
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product portfolio
12.2.5 SWOT ANALYSIS
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
112.3.4 Product Portfolio
112.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PerkinElmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abcam Plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary Of Terms

Note: Product cover images may vary from those shown
3 of 3
  • PerkinElmer, Inc.
  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Cell Signalling Technology, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll